HomeIVBIY • OTCMKTS
add
Innovent Biologics ADR Representing 4 Ord Shs
Previous close
$25.42
Day range
$26.11 - $26.11
Year range
$19.15 - $26.11
Market cap
81.49B HKD
Avg Volume
21.00
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.73B | 56.07% |
Operating expense | 2.00B | 20.21% |
Net income | 148.99M | 133.53% |
Net profit margin | 5.45 | 121.49% |
Earnings per share | — | — |
EBITDA | 136.43M | 136.79% |
Effective tax rate | 5.09% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.88B | -28.13% |
Total assets | 21.60B | 4.73% |
Total liabilities | 8.48B | 4.75% |
Total equity | 13.12B | — |
Shares outstanding | 1.64B | — |
Price to book | 3.17 | — |
Return on assets | 0.90% | — |
Return on capital | 1.22% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 148.99M | 133.53% |
Cash from operations | 751.33M | 94.97% |
Cash from investing | -305.86M | 64.51% |
Cash from financing | -172.91M | -114.76% |
Net change in cash | 279.70M | -60.42% |
Free cash flow | -157.07M | 59.15% |
About
CEO
Founded
Apr 28, 2011
Website
Employees
5,659
